Products

Total PSA Test

OPKO’s prostate-specific antigen (total PSA) test kit is currently undergoing preparations for commercial launch.

Europe:

  • CE mark obtained
  • Expected European commercial launch in late 2012

US:

  • Multi-center study for FDA 510(k) approval commenced December 2011
  • Expected US commercial launch in 2013